Response Framework for GenAI-Enabled Medical Devices
ClaraWell's response to the FDA discussion paper on generative AI-enabled medical devices, examining risk, premarket evidence, postmarket safety, and accountability through patient, clinical, and technological perspectives.
Read publication →